Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.
Press releases published on April 15, 2025
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
GlobeNewswire
·
April 15, 2025
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …
Brazil Food Processing Market Set to Surge to USD 41.05 Bn by 2035, Driven by Automation, Health Trends, & Export Demand
EIN Presswire
·
April 15, 2025
Brazil Food Processing Market Research Report: By Equipment Type Outlook, By Category Outlook and By Application Outlook - Forecast to 2035 BRAZIL, BRAZIL, BRAZIL, April 15, 2025 /EINPresswire.com/ -- Brazil Food Processing Market is poised for …
U.S. Representative Greg Landsman Honored with 2025 Friend of CACFP Award
EIN Presswire
·
April 15, 2025
ROUND ROCK, TX, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- The National CACFP Association proudly announces U.S. Congressional Representative Greg Landsman (D-OH-01) as the recipient of the 2025 Friend of CACFP Award. This prestigious honor …
Koryx Copper Announces Change of Auditor
GlobeNewswire
·
April 15, 2025
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- Koryx Copper Inc. (“Koryx” or the "Company") (TSX-V: KRY) (NSX: KYX) announces that it has changed its auditor from Crowe MacKay LLP (“Former Auditor”) to MNP LLP (“Successor Auditor”) …
Canadian North Resources Inc. Reports Operational and Financial Results for the Year Ended December 31, 2024
GlobeNewswire
·
April 15, 2025
2024 Operational and Project Highlights: Completed and filed the new National Instrument 43-101 Technical Report that defines the large and high-grade Mineral Resources at the 100% owned Ferguson Lake Project (Table 1). 80% of the Indicated Mineral …
Verde Announces Court Approval of Debt Renegotiation Agreement
GlobeNewswire
·
April 15, 2025
The Agreement Secures Extended Payment Terms and Reduced Interest Rates, Enhancing Liquidity SINGAPORE, April 15, 2025 (GLOBE NEWSWIRE) -- Verde Agritech Ltd (TSX: “NPK”) ("Verde” or the “Company”) is pleased to announce that the civil court has …
Robex Announces Entry into Underwriting Agreement
GlobeNewswire
·
April 15, 2025
Not for release to US wire services or distribution in the United States QUÉBEC CITY, April 15, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (TSXV: RBX) (“Robex” or the “Company”) is pleased to announce that it has entered into an underwriting agreement ( …
Er-Kim Announces Exclusive Distribution Agreement with Polaris Pharmaceuticals to Commercialize Pegargiminase (ADZODI) for Malignant Pleural Mesothelioma (MPM) in Multiple EMEA Markets
GlobeNewswire
·
April 15, 2025
ATHENS, Greece and SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Er-Kim Pharmaceuticals, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, today announced it has signed a …
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
GlobeNewswire
·
April 15, 2025
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with relapsed and/or refractory large B-cell lymphoma. RMAT designation recognizes the potential of LYL314 to address significant unmet …
Parexel appoints Charlotte Moser, MD, PhD, MBA as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointment of Charlotte Moser, MD, PhD …
ESGold Corp. Issues Corporate Update as It Advances Toward Production and Expanded Exploration at Montauban
GlobeNewswire
·
April 15, 2025
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- via IBN - ESGold Corp. (“ESGold” or the “Company”) (CSE: ESAU | OTCQB: ESAUF | FSE: Z7D) Canada’s next gold and silver producer, is pleased to provide a corporate update outlining recent …
Bitget Wallet Supports Babylon Mainnet for Seamless BABY and BTC Staking
GlobeNewswire
·
April 15, 2025
SAN SALVADOR, El Salvador, April 15, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, a leading Web3 non-custodial wallet, has announced official support for the Babylon Genesis mainnet. With this integration, users can now easily add the Babylon network in-app, …
EXT Fabrics to Showcase Innovative Textile Solutions at ISA Sign Expo 2025
EIN Presswire
·
April 15, 2025
SANTA ANA, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- EXT Fabrics, a leading provider of large-format digital print solutions specializing in the dye sublimation industry, is excited to announce its participation at the ISA International …
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
GlobeNewswire
·
April 15, 2025
REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in …
Lisata Therapeutics Announces Research License with Catalent
GlobeNewswire
·
April 15, 2025
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
GlobeNewswire
·
April 15, 2025
In combination with atezolizumab or durvalumab Study conducted under the CRADA agreement between NCI and Oryzon MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …
Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
GlobeNewswire
·
April 15, 2025
HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …
Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a Pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in proprietary …
MEXC Sees 170% Surge in Trading Volume Amid Zero-Fee Campaign
GlobeNewswire
·
April 15, 2025
VICTORIA, Seychelles, April 15, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has reported a notable increase in trading activity following the launch of its Zero-Fee Trading Campaign in the first quarter of 2025. The program …
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug …